Advertising Spillovers: Drug Detailing in Combination Therapy

Promotion Spillovers: Drug Detailing in Combination Therapy

Marketing Science ◽

10.1287/mksc.2016.1014 ◽

2017 ◽

Vol 36 (3) ◽

pp. 382-401 ◽

Cited By ~ 9

Author(s):

Hongju Liu ◽

Qiang Liu ◽

Pradeep K. Chintagunta

Keyword(s):

Combination Therapy ◽

Drug Detailing

Download Full-text

High dose induction therapy with consensus interferon followed by combination therapy with ribavirin for treatment-naive hepatitis C patients

Gastroenterology ◽

10.1016/s0016-5085(01)81904-1 ◽

2001 ◽

Vol 120 (5) ◽

pp. A383-A383

Author(s):

S KALSER ◽

C KREYSEL ◽

H HASS ◽

M GREGOR

Keyword(s):

Hepatitis C ◽

Combination Therapy ◽

Induction Therapy ◽

High Dose ◽

Consensus Interferon ◽

Treatment Naïve

Download Full-text

Octreotide monotherapy versus combination therapy with octreotide and alpha-interferon in patients with metastatic neuroendocrine gastroenteropancreatic (GEP) carcinoma

Gastroenterology ◽

10.1016/s0016-5085(01)83796-3 ◽

2001 ◽

Vol 120 (5) ◽

pp. A762-A762

Author(s):

M WIED ◽

A SPRENGER ◽

H MUELLER ◽

K KLOSE ◽

R ARNOLD

Keyword(s):

Combination Therapy ◽

Alpha Interferon

Download Full-text

617: Combination Therapy with Plasmin-Cleaved Beta-2-Glycoprotein 1 and Docetaxel Inhibits the Growth of Orthotopically Implanted Tramp Murine Prostate Cancer Cells

The Journal of Urology ◽

10.1016/s0022-5347(18)37879-0 ◽

2004 ◽

Vol 171 (4S) ◽

pp. 164-164

Author(s):

Daniel D. Cohen ◽

Weixin Lu ◽

Alan J. Schroit

Keyword(s):

Prostate Cancer ◽

Combination Therapy ◽

Cancer Cells ◽

Prostate Cancer Cells ◽

Beta 2

Download Full-text

Dry Eye Responds Best to Combination Therapy

Skin & Allergy News ◽

10.1016/s0037-6337(08)70087-1 ◽

2008 ◽

Vol 39 (2) ◽

pp. 69

Author(s):

CAROLINE HELWICK

Keyword(s):

Combination Therapy ◽

Dry Eye

Download Full-text

Combination Therapy Often Best for Acne Management

Internal Medicine News ◽

10.1016/s1097-8690(05)70458-3 ◽

2005 ◽

Vol 38 (1) ◽

pp. 22

Author(s):

Debra Wood

Keyword(s):

Combination Therapy

Download Full-text

Combination Therapy for HCV Assessed

Internal Medicine News ◽

10.1016/s1097-8690(06)73816-1 ◽

2006 ◽

Vol 39 (13) ◽

pp. 48-49

Author(s):

MARY ELLEN SCHNEIDER

Keyword(s):

Combination Therapy

Download Full-text

Abstract #805218: Combination Therapy with Once Weekly GLP 1 Receptor Agonist Dulaglutide and Basal Insulin Analogues in Asian Indians with Type 2 Diabetes

Endocrine Practice ◽

10.1016/s1530-891x(20)39612-9 ◽

2020 ◽

Vol 26 ◽

pp. 117-118

Author(s):

Brijendra Srivastava

Keyword(s):

Type 2 Diabetes ◽

Combination Therapy ◽

Basal Insulin ◽

Receptor Agonist ◽

Asian Indians ◽

Insulin Analogues

Download Full-text

Abstract #1141: Efficacy and Safety of Initial Combination Therapy with Canagliflozin (CANA) and Metformin Extended-Release (Met) in Drug-Naïve Patients with Type 2 Diabetes Mellitus (T2DM) By Latino/Hispanic Ethnicity

Endocrine Practice ◽

10.1016/s1530-891x(20)44270-3 ◽

2017 ◽

Vol 23 ◽

pp. 312

Author(s):

Jaime Davidson ◽

Julio Rosenstock ◽

Ujjwala Vijapurkar ◽

Michael Davies ◽

Anita Conner ◽

...

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Type 2 Diabetes Mellitus ◽

Combination Therapy ◽

Extended Release ◽

Efficacy And Safety ◽

Initial Combination Therapy ◽

Drug Naïve ◽

Initial Combination

Download Full-text

Abstract #582 Endocrine Consequences of Combination Therapy of Immune Checkpoint Inhibitors in Cancer Patients

Endocrine Practice ◽

10.1016/s1530-891x(20)46926-5 ◽

2019 ◽

Vol 25 ◽

pp. 297-298

Author(s):

Sevil Aliyeva ◽

Pamela Schroeder ◽

Issam Cheikh

Keyword(s):

Combination Therapy ◽

Cancer Patients ◽

Immune Checkpoint ◽

Immune Checkpoint Inhibitors ◽

Checkpoint Inhibitors

Download Full-text